One‑Year Outcomes in a Supervised Program of Swallowable Intragastric Balloon—Analysis of 486 Patients in a High‑Volume Bariatric Centre in Malaysia
Nik Ritza Kosai1,2 · Aishath Azna Ali3 · Ryan Ghita4 · Guhan Muthkumaran1 · Ismail Ali1 · Guo Hou Loo1 ·
Firdaus Hayati5
The ongoing struggle against the obesity pandemic has
been a persistent endeavour. Based on the most recent
report released by the World Health Organisation (WHO),
it has been determined that in 2016, a total of over 1.9 billion
individuals aged 18 years and older were found to be
suffering from being overweight. Among this population,
approximately 650 million adults were identified as being
affected by obesity [1]. The global prevalence of obesity has
experienced a significant increase over four decades. Among
the Southeast Asian nations, Malaysia has emerged with the
highest prevalence, reaching 19.7% in 2019 compared to
15.1% in 2011 [2, 3].
